Bavarian Nordic A/S (CPH:BAVA)
241.60
-6.60 (-2.66%)
Nov 20, 2026, 10:59 AM CET
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.80B DKK in the quarter ending September 30, 2026, with 0.56% growth. This brings the company's total for the last twelve months to 6.35B, down -7.82% year-over-year. In the year 2025, Bavarian Nordic had annual revenue of 6.24B with 9.23% growth. That makes Bavarian Nordic the 7,961st largest company in the world by revenue and 40th in Denmark.
Revenue (ttm)
6.35B
Revenue Growth
-7.82%
P/S Ratio
2.92
Revenue / Employee
3.30M
Employees
1,906
Market Cap
18.02B
Revenue by Geography
- USA 2.70B 43.2%
- Germany 1.16B 18.6%
- France 723.95M 11.6%
- Other Geographic Markets 518.95M 8.3%
- Canada 223.46M 3.6%
- England 213.59M 3.4%
- Finland 182.51M 2.9%
- Other 524.49M 8.4%
Fiscal year ended Dec 31, 2025 See the full Bavarian Nordic breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.24B | 527.75M | 9.23% |
| Dec 31, 2024 | 5.72B | -1.35B | -19.06% |
| Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
| Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
| Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 333.65B |
| Coloplast | 28.94B |
| Genmab | 28.27B |
| H. Lundbeck | 26.28B |
| Demant | 24.63B |
| GN Store Nord | 16.52B |
| ALK-Abelló | 7.06B |
| Embla Medical | 6.56B |
Bavarian Nordic News
- 6 days ago - Bavarian Nordic Earnings Call Transcript: Q3 2026 - Transcripts
- 6 days ago - Bavarian Nordic Quarterly report: Q3 2026 - Filings
- 6 days ago - Bavarian Nordic Slides: Q3 2026 - Filings
- 7 days ago - Bavarian Nordic beats Q3 revenue expectations - Reuters
- 18 days ago - Bavarian Nordic Awarded 4 Year Mpox And Smallpox Vaccine Supply Contract By UK Government - Nasdaq
- 18 days ago - Bavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK government - Reuters
- 23 days ago - Bavarian Nordic donates 75,000 mpox vaccine doses to global emergency stockpile - Reuters
- 3 months ago - Bavarian Nordic Earnings Call Transcript: Q2 2026 - Transcripts